Skip to main content

Table 4 Lab values

From: A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss

Variable

LLLT (N = 15)

Lorcaserin (N = 14)

Combination (N = 13a)

RBC

 Baseline

4.59 ± 0.32

4.75 ± 0.43

4.80 ± 0.41

 Week 12

4.61 ± 0.29

4.70 ± 0.42

4.65 ± 0.34

 Delta

+0.01 ± 0.20

−0.06 ± 0.17

−0.15 ± 0.26

Hemoglobin

 Baseline

13.77 ± 0.92

14.34 ± 1.26

14.00 ± 1.26

 Week 12

13.83 ± 0.81

14.08 ± 1.28

13.55 ± 1.15

 Delta

+0.07 ± 0.57

−0.26 ± 0.61

−0.45 ± 0.86

Hematocrit

 Baseline

41.35 ± 2.07

42.81 ± 3.00

42.17 ± 2.82

 Week 12

41.53 ± 2.13

42.03 ± 2.92

40.78 ± 2.67

 Delta

+0.17 ± 1.82

−0.77 ± 1.93

−1.39 ± 2.37

MCV

 Baseline

90.19 ± 4.38

90.21 ± 3.18

88.09 ± 4.07

 Week 12

90.29 ± 3.69

89.66 ± 3.76

87.86 ± 4.00

 Delta

+0.10 ± 2.05

−0.56 ± 2.08

−0.23 ± 1.86

RDW

 Baseline

13.23 ± 0.74

13.11 ± 0.50

13.41 ± 0.61

 Week 12

13.19 ± 0.58

12.96 ± 0.49

13.22 ± 0.69

 Delta

−0.04 ± 0.40

−0.14 ± 0.37

−0.19 ± 0.48

WBC

 Baseline

6.83 ± 1.71

7.20 ± 1.45

6.98 ± 1.28

 Week 12

5.99 ± 1.41

6.81 ± 2.11

6.32 ± 1.57

 Delta

−0.83 ± 1.26*

−0.39 ± 1.08

−0.66 ± 1.11

Neutrophils

 Baseline

4.03 ± 1.58

4.15 ± 1.12

4.29 ± 1.08

 Week 12

3.30 ± 1.10

3.99 ± 1.72

3.78 ± 1.20

 Delta

−0.74 ± 1.17*

−0.16 ± 0.99

−0.51 ± 0.77*

Lymphocytes

 Baseline

2.04 ± 0.41

2.22 ± 0.55

2.00 ± 0.39

 Week 12

1.93 ± 0.38

2.03 ± 0.41

1.84 ± 0.53

 Delta

−0.11 ± 0.25

−0.19 ± 0.43

−0.16 ± 0.39

Monocytes

 Baseline

0.51 ± 0.13

0.60 ± 0.19

0.49 ± 0.13

 Week 12

0.47 ± 0.13

0.58 ± 0.22

0.47 ± 0.10

 Delta

−0.05 ± 0.12

−0.02 ± 0.12

−0.03 ± 0.06

Eosinophils

 Baseline

0.22 ± 0.12

0.18 ± 0.11

0.16 ± 0.05

 Week 12

0.26 ± 0.18

0.17 ± 0.11

0.19 ± 0.15

 Delta

+0.04 ± 0.11

−0.01 ± 0.06

+0.03 ± 0.15

Basophils

 Baseline

0.03 ± 0.02

0.04 ± 0.03

0.03 ± 0.02

 Week 12

0.04 ± 0.02

0.04 ± 0.03

0.03 ± 0.01

 Delta

+0.01 ± 0.02

−0.00 ± 0.02

+0.00 ± 0.01

Platelets

 Baseline

251.4 ± 56.6

287.0 ± 69.3

292.9 ± 60.3

 Week 12

253.4 ± 51.2

277.1 ± 70.9

287.4 ± 47.7

 Delta

+2.0 ± 20.8

−9.9 ± 27.3

−5.5 ± 26.0

  1. *p < 0.05, for paired t-test comparing week 12 versus baseline
  2. aOf the 15 subjects assigned to the combination group, 2 discontinued prior to week 12 and are not included in the analysis